MicroPort CardioFlow

Company

Investment-firm

Last deal

$130M

Amount

Private Equity

Stage

21.04.2020

Date

1

all rounds

$130M

Total amount

General

About Company
Shanghai MicroPort CardioFlow Medtech provides advanced minimally invasive therapies for structural heart diseases.

Related to

MicroPort (Shanghai)

MicroPort (Shanghai)

MicroPort (Shanghai) is a Chinese medical devices company specialising in minimally invasive products for treating vascular disease.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Health Care, Medical Device, Manufacturing

Location

Shanghai, China

total rounds

4

total raised

$1.3M

count Of Investments

2

Industry

Sector :

Subsector :

Keywords :

Also Known As

微创心通

founded date

01.01.2015

Number of employees

Company Type

For Profit

Last funding type

Private Equity

IPO status

Private

Description

MicroPort CardioFlow, a subsidiary of MicroPort Scientific Corporation, is a medical device company in China that focuses on developing and commercializing transcatheter and surgical solutions for valvular heart diseases. The company's product portfolio includes VitaFlow, VitaFlow Liberty, Alwide Plus, and various other products for TAVI, TMV, TTV, surgical valve, and procedural accessories. With a global vision to provide affordable, reliable, and superior products, the company aims to save and improve the quality of life for patients. While the company derives a majority of its revenue from China, it is committed to bringing innovative valvular disease treatment solutions to patients worldwide.